BackHubei Jumpcan Pharmaceutical , Ltd. Overview

Hubei Jumpcan Pharmaceutical , Ltd. Current Assets

Track Hubei Jumpcan Pharmaceutical , Ltd.'s current assets ($13B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$13.44B
↑ 3.06% YoYΔ $399.35M vs prior year quarter

Peer trimmed avg / median

Loading

Hubei Jumpcan Pharmaceutical , Ltd. Current Assets History

Loading

Hubei Jumpcan Pharmaceutical , Ltd. vs. peers: Current Assets Comparison

Loading

Hubei Jumpcan Pharmaceutical , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hubei Jumpcan Pharmaceutical , Ltd. (600566.SS) FAQ

As of the most recent data (June 2026), 600566.SS shows a current assets of $13B. That compares with $13B in the prior-year period — up 3.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600566.SS's current assets is now $13B (was $13B) — a 3.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hubei Jumpcan Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 600566.SS's current assets over time shows whether Hubei Jumpcan Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $13B That compares with $13B in the prior-year period — up 3.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Hubei Jumpcan Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $13B) with ownership activity and broader fundamentals.